MHRA to conduct market surveillance of medical devices in Europe

20 November 2016 (Last Updated November 20th, 2016 18:30)

The Medicines and Healthcare products Regulatory Agency (MHRA) will conduct surveillance on the safety and functionality of medical devices used in households across Europe.

The Medicines and Healthcare products Regulatory Agency (MHRA) will conduct surveillance on the safety and functionality of medical devices used in households across Europe.

The effort is a part of a project termed as Joint Action on Market Surveillance of Medical Devices, launched officially by MHRA on 19 October this year.

MHRA director of medical devices John Wilkinson said: “We are pleased to be leading this important activity and look forward to working with our colleagues across the EU in delivering improvements to reinforce market surveillance.”

"We are pleased to be leading this important activity and look forward to working with our colleagues across the EU in delivering improvements to reinforce market surveillance."

The project is intended to reinforce the market surveillance system for medical devices by promoting the coordination of activities by all member states of the European Union, and ensuring adequate communications and cooperation considered important for the success and effectiveness of the market surveillance in the field of medical devices.

The Joint Action will be executed through five work packages, out of which MHRA will lead on three fields that are coordination, dissemination and evaluation, while the other two will be executed by EU member states the Netherlands and Ireland on the fields of manufacturers’ inspection and clinical process and resource development respectively.

The project will support the Consumers, Health, Agriculture and Food Executive Agency’s (Chafea) programme of community action within the field of health.